Figure_3.tif (616.43 kB)
Potential utility of FGFR2 mutation status as an adverse prognostic factor to affect clinical decision-making.
figure
posted on 2012-02-23, 01:53 authored by Sara A. Byron, Michael Gartside, Matthew A. Powell, Candice L. Wellens, Feng Gao, David G. Mutch, Paul J. Goodfellow, Pamela M. PollockThe decision tree is adapted from 2011 National Comprehensive Cancer Network guidelines using FIGO 2009 staging. BT = brachytherapy; RT = radiation therapy.
